Royal Bank of Canada’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Royal Bank of Canada's AMGN Position: Q1 2026 in Review
Royal Bank of Canada reduced its Amgen (AMGN) stake by 5% in Q1 2026, selling an estimated $83.2M and leaving 4,471,445 shares worth $1.57B. The position accounts for 0.28% of the portfolio, ranked #68.
Royal Bank of Canada first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.68B in Q4 2023. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Royal Bank of Canada held 4,471,445 shares of Amgen worth $1.57B as of Q1 2026.
- Royal Bank of Canada sold 233,485 Amgen shares in Q1 2026, an estimated $83.2M.
- Amgen made up 0.28% of Royal Bank of Canada's portfolio in Q1 2026, its #68 holding.
- Royal Bank of Canada first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's Amgen position peaked at $1.68B in Q4 2023.
- 3,137 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.